Family · Pharmaceutical analytical standards
Mianserin
A tetracyclic antidepressant that acts mainly by blocking alpha-2 adrenergic, serotonin and histamine receptors: patented in the Netherlands in 1967, it has been on the market since the mid-1970s. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Mirtazapine, a newer antidepressant, is almost a copy of it: it differs only by one nitrogen atom in place of a carbon in one of the rings, so much so that it is also called 6-aza-mianserin.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
